AB SCIENCE (AB) 0.672 EUR (-3.03%) | Healthcare Euronext / Paris

AB SCIENCE is a biopharmaceutical company focused on the research, development, and commercialization of drugs for the treatment of severe diseases in oncology and inflammatory diseases.

Momentum is very weak and the trend remains deeply bearish, reflecting a speculative profile driven more by uncertainty than by established fundamental momentum. The absence of recent news provides no visible short-term catalyst; for investors, the stock is more of a high-volatility clinical bet than a trend-following equity.

AB SCIENCE

Trend Analysis of AB SCIENCE

Want to see the full analysis?